An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)

Author： Jung Norma   Hellmann Matthias   Hoheisel Reimund   Lehmann Clara   Haase Ingo   Perniok Andreas   Hallek Michael   Rubbert Andrea  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.29, Iss.10, 2010-10, pp. : 1169-1173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 6, 2007-04 ,pp. : 401-405

Karger

Access to resources Recommend Favorite

Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study

By  

Digestion, Vol. 93, Iss. 3, 2016-03 ,pp. : 193-201

Karger

Access to resources Recommend Favorite

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

By Bijl Arie   Breedveld Ferdinand   Antoni Christian   Kalden Joachim   Kary Sonja   Burmester Gerd   Beckmann Christina   Unnebrink Kristina   Kupper Hartmut  

Clinical Rheumatology, Vol. 27, Iss. 8, 2008-08 ,pp. : 1021-1028

Springer Publishing Company

Access to resources Recommend Favorite

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

By Okita Kiwamu   Sakaida Isao   Okada Mitsuru   Kaneko Akira   Chayama Kazuaki   Kato Michio   Sata Michio   Yoshihara Naomasa   Ono Noriyuki   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 45, Iss. 9, 2010-09 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

By Okita Kiwamu   Sakaida Isao   Okada Mitsuru   Kaneko Akira   Chayama Kazuaki   Kato Michio   Sata Michio   Yoshihara Harumasa   Ono Noriyuki   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 45, Iss. 9, 2010-09 ,pp. : 997-997

Springer Publishing Company

Access to resources Recommend Favorite